FISPB
BIO icon

Fideuram - Intesa Sanpaolo Private Banking’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
+8,221
New +$2.33M 0.07% 209

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's BIO Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 8,221 shares worth $2.41M. The stake represents 0.07% of the portfolio and ranks #209 among its holdings.

190 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 8,221 shares of Bio-Rad Laboratories Class A worth $2.41M as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new Fideuram - Intesa Sanpaolo Private Banking position in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.07% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #209 holding.
  • 190 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.